Medicaid Prescription Drugs: Pricing & Policy Issues | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Sandra Olivia Barton
Category1=Non-Fiction
Category=LNTJ
Category=LNTM
Category=MBP
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=In stock
Price_€100 and above
PS=Active
softlaunch

Medicaid Prescription Drugs: Pricing & Policy Issues

English

Medicaid is a federal-state entitlement program that pays for health care and related services on behalf of certain low-income individuals. Prescription drugs are an optional Medicaid benefit and all states cover outpatient drugs. States can create formularies, or lists of preferred drugs, but federal rules tend to result in comprehensive coverage, even for beneficiaries enrolled in Medicaid managed care plans. Pharmaceutical manufacturers that voluntarily participate in Medicaid are required to pay rebates to states on covered outpatient drugs, which help Medicaid receive manufacturers'' lowest or best price. States then share the rebate they receive from pharmaceutical manufacturers with the federal government. This book discusses Medicaid prescription drug pricing and policies. See more
Current price €168.14
Original price €176.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Sandra Olivia BartonCategory1=Non-FictionCategory=LNTJCategory=LNTMCategory=MBPCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=In stockPrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 310g
  • Dimensions: 155 x 230mm
  • Publication Date: 01 Jun 2015
  • Publisher: Nova Science Publishers Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781634825221
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept